Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP
Report ID | 163226 |
Drug Identification Number | 02239944 |
Brand name | KETOROLAC TROMETHAMINE INJECTION USP |
Common or Proper name | KETOROLAC TROME |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | KETOROLAC TROMETHAMINE |
Strength(s) | 30MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1ML 10LIVI |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-22 |
Estimated end date | 2022-08-19 |
Actual end date | 2022-06-29 |
Shortage status | Resolved |
Updated date | 2022-06-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-06-30 | English | Compare |
v5 | 2022-06-29 | French | Compare |
v4 | 2022-06-29 | English | Compare |
v3 | 2022-06-23 | English | Compare |
v2 | 2022-06-22 | French | Compare |
v1 | 2022-06-22 | English | Compare |
Showing 1 to 6 of 6